Influx Healthtech Ltd

Influx Healthtech Ltd IPO

IPO Price Range: ₹91 - 96

Influx Healthtech Limited is a Mumbai-based, healthcare focused company specialising in contractmanufacturing. Since its inception in 2020, the Company has established itself as a reliable ContractDevelopment and Manufacturing Organization (CDMO), offering production of Dietary andNutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements,Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms,including tablets, capsules, and injectables.

Min Investment

₹1,15,200

IPO Size

₹58 Cr

IPO Status

Upcoming

Quantity in 1 Lot

1200

Max Bid allowed

1

Listing Exchange

NSE

IPO Application Timeline of Influx Healthtech Ltd

upcoming
Open Date18 Jun 2025
Close Date20 Jun 2025
Allotment Date23 Jun 2025
Listing Date25 Jun 2025

Key Statistics

Bid Opening DateBid Opening Date18 Jun 2025
Bid Closing DateBid Closing Date20 Jun 2025
Allotment DateAllotment Date23 Jun 2025
Issue SizeIssue Size₹58.57Cr
Quantity in 1 lotQuantity in 1 lot1200

Strengths and Risks of Influx Healthtech Ltd IPO

Strengths

Strengths

  • Diverse client base with longstanding CDMO relationships.

  • Well versed and equipped advanced manufacturing facilities with global accreditations.

  • Large and rapidly growing R&D capabilities across our product portfolio.

  • Experienced Promoter and management team with strong industry expertise and successful track record.

  • Robust Quality Assurance & Control practices.

  • Proven Track record of growth and profitability.


Risks

Risks

  • Our Company is reliant on the demand from the nutraceutical industry for a significant portion of our revenue. Any downturn in the nutraceutical industry or an inability to increase or effectively manage our sales could have an adverse impact on our Companys business and results of operations.

  • Our existing manufacturing facility are concentrated in a single region i.e., Palghar, Thane, Maharashtra and the inability to operate and grow our business in this particular region may have an adverse effect on our business, financial condition, results of operations, cash flows and future business prospects.

  • Our Company is dependent on few numbers of customers for sales. Loss of any of this large customer may affect our revenues and profitability.

  • We have historically derived, and may continue to derive, a significant portion of our supply from top 10 Suppliers. Also, Our Company has not entered into long-term agreements with these suppliers. In the event we are unable to procure adequate amounts of raw materials, at competitive prices our business, results of operations and financial condition may be adversely affected.

  • Too much Geographical concentration of our Business on specific location can impact our Business.

  • Our reliance on certain industries for a significant portion of our sales could have an adverse effect on our business.

  • We have not taken any steps to order the machinery/equipment required for the proposed expansion. In the event of any delay in placing the orders, or in the event the vendors are not able to provide the equipment / machineries in a timely manner, or at all, the same may result in time and cost over-runs.

  • Our business activities are exposed to fluctuations in the prices of raw materials.

  • We may face several risks associated with the construction of the building of the Proposed Expansion, which could hamper our growth, prospects, cash flows and business and financial condition

  • Our Registered Office, Factory Units and Godown is located on premises which are not owned by us and has been obtained on license basis from the promoters of our company. Disruption of our rights as licensee/ lessee or termination of the agreements with our licensors/ lessors (promoters) may adversely impact our operations and, consequently, our business, financial condition and results of operations.

Promoters Holding

Investors Holdings %
Munir Abdul Ganee Chandniwala95%
Shirin Munir Ahmed Chandniwala4.85%
Abdul Ganee Abdul Rasul Chandn0%

Frequently Asked Questions of Influx Healthtech Ltd IPO

  • What is the size of the Influx Healthtech Ltd IPO?

    The size of the Influx Healthtech Ltd IPO is ₹58.57Cr .

  • What is 'pre-apply' for Influx Healthtech Ltd IPO?

    'Pre-apply' for Influx Healthtech Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.

  • When will my Influx Healthtech Ltd IPO order be placed?

    Your Influx Healthtech Ltd IPO order will be placed on 18 Jun 2025.

  • What are the open and close dates of the Influx Healthtech Ltd IPO?

    The open and close dates of the Influx Healthtech Ltd IPO are 18 Jun 2025 to 20 Jun 2025.

  • What is the lot size and minimum order quantity of the Influx Healthtech Ltd IPO?

    The lot size and minimum order quantity of the Influx Healthtech Ltd IPO are 1200 and 1200 respectively.

  • What would be the listing gains on the Influx Healthtech Ltd IPO?

    The potential listing gains on the Influx Healthtech Ltd IPO will depend on various market factors and cannot be predicted with certainty.